TARS1 and breast cancer: TARS1 was successfully knocked down in MDA-MB-231, SKBR3 and MCF-7 cells using siRNA (Figures 11B–D), and CCK8 (Figures 12A–C) and clone formation (Figures 12D, E) assays revealed that breast cancer cell proliferation was significantly reduced.